Global Pharmaceuticals and Healthcare Report Q3 2017
BMI View: The global pharmaceutical market will continue to be heavily regulated. This is becausemedicines can have serious side effects, even when properly produced, distributed correctly and consumedas instructed. Pharmaceuticals are also high-margin goods that are relatively easy to manufacture, makingthem an attractive option for illicit production. Drugmakers that appreciate the evolving regulatorylandscape will outperform.
The global pharmaceutical market has a Risk/Reward Index (RRI) score of 50.0 out of 100 in Q317(unchanged from Q217). With a score of 74.8, Western Europe is the leading region, followed by AsiaPacific (53.5), Central and Eastern Europe (52.5) the Americas (48.7), the Middle East & North Africa(47.8), and Sub-Saharan Africa (26.8).